{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:21:39Z","timestamp":1788895299398,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574173"],"award-info":[{"award-number":["82574173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003516"],"award-info":[{"award-number":["82003516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jctube.2025.100568","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:04:44Z","timestamp":1760659484000},"page":"100568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of tuberculosis on median survival time and years of potential life lost in patients: A scoping review"],"prefix":"10.1016","volume":"41","author":[{"given":"Jingxian","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2025.100568_b0005","unstructured":"World Health Organization (2024) Global tuberculosis report 2024. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"issue":"10","key":"10.1016\/j.jctube.2025.100568_b0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jctube.2025.100568_b0015","doi-asserted-by":"crossref","unstructured":"Lee-Rodriguez C, Wada PY, Hung YY, Skarbinski J. Association of Mortality and Years of Potential Life Lost With Active Tuberculosis in the United States. JAMA network open. Sep 1 2020;3(9):e2014481. doi:10.1001\/jamanetworkopen.2020.14481.","DOI":"10.1001\/jamanetworkopen.2020.14481"},{"issue":"4","key":"10.1016\/j.jctube.2025.100568_b0020","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ije\/dyad039","article-title":"Life expectancy among patients with pulmonary tuberculosis is less than one-third of life expectancy in the background population in Guinea-Bissau-an observational study","volume":"52","author":"Bohlbro","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jctube.2025.100568_b0025","doi-asserted-by":"crossref","unstructured":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). May 18 2024;403(10440):2100-2132. doi:10.1016\/s0140-6736(24)00367-2.","DOI":"10.1016\/S0140-6736(24)00367-2"},{"key":"10.1016\/j.jctube.2025.100568_b0030","article-title":"Changes and trend disparities in life expectancy and health-adjusted life expectancy attributed to disability and mortality from 1990 to 2019 in China","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"issue":"10","key":"10.1016\/j.jctube.2025.100568_b0035","doi-asserted-by":"crossref","first-page":"e1372","DOI":"10.1016\/S2214-109X(21)00299-0","article-title":"Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis","volume":"9","author":"Silva","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jctube.2025.100568_b0040","doi-asserted-by":"crossref","unstructured":"Matteelli A, Lovatti S, Rossi B, Rossi L. Update on MDR-TB preventive therapy towards the global TB elimination. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Feb 22 2025:107849. doi:10.1016\/j.ijid.2025.107849.","DOI":"10.1016\/j.ijid.2025.107849"},{"issue":"2","key":"10.1016\/j.jctube.2025.100568_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000351","article-title":"Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study","volume":"1","author":"Balabanova","year":"2011","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jctube.2025.100568_b0050","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"Dodd","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.jctube.2025.100568_b0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jctube.2025.100568_b0060","doi-asserted-by":"crossref","unstructured":"Modig K, Rau R, Ahlbom A. Life expectancy: what does it measure? BMJ open. Jul 22 2020;10(7):e035932. doi:10.1136\/bmjopen-2019-035932.","DOI":"10.1136\/bmjopen-2019-035932"},{"issue":"2","key":"10.1016\/j.jctube.2025.100568_b0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1353\/dem.0.0098","article-title":"Three measures of longevity: time trends and record values","volume":"47","author":"Canudas-Romo","year":"2010","journal-title":"Demography"},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0070","first-page":"219","article-title":"Burden of disease analysis for tuberculosis chinese","volume":"29","author":"Wang","year":"2007","journal-title":"Journal of AntiTuberculosis"},{"key":"10.1016\/j.jctube.2025.100568_b0075","first-page":"385","article-title":"Long-term survival of treated tuberculosis patients in comparison to a general population in south india: a matched cohort study","volume":"110","author":"Selvaraju","year":"2021","journal-title":"Int J infectious diseases : IJID : official publication Int Soc Infectious Diseases"},{"key":"10.1016\/j.jctube.2025.100568_b0080","doi-asserted-by":"crossref","unstructured":"Kempen WV. [Fate and life expectancy of children with active tuberculosis]. Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung. 1951;106(2):153-7. Schicksal und Lebenseiwartung der offentuberkul\u00f6sen Jugendlichen.","DOI":"10.1007\/BF02145635"},{"key":"10.1016\/j.jctube.2025.100568_b0085","unstructured":"Toledo Vila Hde J, Padilla P\u00e9rez O, Vidal Garc\u00eda I, Rodr\u00edguez Avila I. [Tuberculosis mortality in Cuba, 1987-1993]. Revista cubana de medicina tropical. 1996;48(3):209-13. Mortalidad por tuberculosis en Cuba, 1987-1993."},{"issue":"1\u20132","key":"10.1016\/j.jctube.2025.100568_b0090","first-page":"25","article-title":"Decline of tuberculosis mortality in an urban Mexican-origin population, 1935-1984","volume":"44","author":"Bradshaw","year":"1997","journal-title":"Social biology Spring-Summer"},{"issue":"2","key":"10.1016\/j.jctube.2025.100568_b0095","first-page":"465","article-title":"Diseases in European historical populations and their effects on individuals and society","volume":"22","author":"Jankauskas","year":"1998","journal-title":"Coll Antropol"},{"key":"10.1016\/j.jctube.2025.100568_b0100","doi-asserted-by":"crossref","unstructured":"Canelo JA, Sard\u00f3n MA, Pardo MM, Le\u00f3n IL, Gonz\u00e1lez Mdel C. [Premature death from infectious diseases in Spain, 1908-1995]. Revista panamericana de salud publica = Pan American journal of public health. Oct 2002;12(4):262-8. Mortalidad prematura por enfermedades infecciosas en Espa\u00f1a, 1908-1995. doi:10.1590\/s1020-49892002001000007.","DOI":"10.1590\/S1020-49892002001000007"},{"issue":"Suppl 1","key":"10.1016\/j.jctube.2025.100568_b0105","first-page":"S3","article-title":"Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries","volume":"12","author":"Boerma","year":"1998","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.jctube.2025.100568_b0110","unstructured":"Klonowicz S. [Mortality from tuberculosis and the average life expectancy in Poland]. Pneumonologia polska. May 1976;44(5):421-8. Umieralno\u015b\u0107 na gru\u017alice a przecietne trwanie \u017aycia w Polsce."},{"key":"10.1016\/j.jctube.2025.100568_b0115","unstructured":"Mortensen J, Lange P, Viskum K. [Life expectancy and prognosis for employment after contracting tuberculosis]. Lebensversicherungs Medizin. Sep 1 1987;39(5):149-51. Lebenserwartung und Prognose zur Erwerbst\u00e4tigkeit nach Erkrankung an Tuberkulose."},{"key":"10.1016\/j.jctube.2025.100568_b0120","unstructured":"Rickards BR, Slack FH, Arms BL. Longevity of B. Tuberculosis in Sputum. American journal of public hygiene. Aug 1909;19(3):586-94."},{"key":"10.1016\/j.jctube.2025.100568_b0125","unstructured":"Bottner H, Schlegel B. [Longevity of transfused erythrocytes in tuberculosis]. Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung. 1954;111(1-2):155-7. Die Lebensdauer \u00fcbertragener Erythrocyten bei Kranken mit Tuberkulose."},{"key":"10.1016\/j.jctube.2025.100568_b0130","unstructured":"Karlin M. [Tuberculosis as a disease of civilization and longevity]. Priroda, clovek in zdravje. Aug-Sep 1950;5(8-9):226-30. Izvzem6si tuberkulozo nara6s6cajotako imenovane bolezni civiliziranih narodov, ker se je podalj6sala 6zivljenjska doba."},{"key":"10.1016\/j.jctube.2025.100568_b0135","unstructured":"Myers JA, Hartig H. Tuberculosis lingers as the life span lengthens. Part II. Geriatrics. Dec 1959;14:801-11."},{"key":"10.1016\/j.jctube.2025.100568_b0140","first-page":"709","article-title":"Tuberculosis lingers as the life span lengthens","volume":"14","author":"Myers","year":"1959","journal-title":"I Geriatrics"},{"key":"10.1016\/j.jctube.2025.100568_b0145","unstructured":"De Cancella LC. [Effects of pulmonary tuberculosis on the duration of life]. Medicina contemporanea (Lisbon, Portugal). Sep 1958;76(9):403-8. Influence de la tuberculose pulmonaire sur la dur\u00e9e de la vie."},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5588\/ijtld.23.0588","article-title":"Post-TB lung disease: keep going beyond TB!","volume":"28","author":"Pontali","year":"2024","journal-title":"The Int J tuberculosis and lung disease : The official J Int Union against Tuberculosis and Lung Disease"},{"issue":"6","key":"10.1016\/j.jctube.2025.100568_b0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S2213-2600(22)00102-3","article-title":"Making a case for investing in post-tuberculosis lung health in children","volume":"10","author":"Nkereuwem","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jctube.2025.100568_b0160","unstructured":"Control of infectious diseases. MMWR Morbidity and mortality weekly report. Jul 30 1999;48(29):621-9."},{"issue":"2","key":"10.1016\/j.jctube.2025.100568_b0165","first-page":"133","article-title":"The long term(9-year)survival of multidrug-resistant tuberculosis patients compared to non\u2014multi-drug\u2014resistant tuberculosis patients in Henan province","volume":"34","author":"Sun","year":"2013","journal-title":"Chin J Epidemiol"},{"issue":"2","key":"10.1016\/j.jctube.2025.100568_b0170","first-page":"54","article-title":"Medical information Comparative analysis of survival between multidrug-resistant tuberculosis patients and non-multidrug-resistant patients in Ningxia","volume":"30","author":"Pan","year":"2017","journal-title":"China Medical Information"},{"issue":"03","key":"10.1016\/j.jctube.2025.100568_b0175","first-page":"224","article-title":"Survival analysis of pneumoconiosis complicated with tuberculosis from 1953 to 2005 in shanghai","volume":"26","author":"Peng","year":"2009","journal-title":"J Environ Occup Med"},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031786","article-title":"Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa","volume":"7","author":"Shenoi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100568_b0185","doi-asserted-by":"crossref","unstructured":"Han L, Gao Q, Yang J, et al. Survival Analysis of Coal Workers' Pneumoconiosis (CWP) Patients in a State-Owned Mine in the East of China from 1963 to 2014. International journal of environmental research and public health. May 6 2017;14(5)doi:10.3390\/ijerph14050489.","DOI":"10.3390\/ijerph14050489"},{"key":"10.1016\/j.jctube.2025.100568_b0190","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018053","article-title":"Life expectancy of HIV-positive patients after diagnosis in Iran from 1986 to 2016: a retrospective cohort study at national and sub-national levels","volume":"40","author":"Mirzaei","year":"2018","journal-title":"Epidemiology and health"},{"issue":"9","key":"10.1016\/j.jctube.2025.100568_b0195","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/thorax.57.9.810","article-title":"A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK","volume":"57","author":"Drobniewski","year":"2002","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jctube.2025.100568_b0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1164\/rccm.200911-1656OC","article-title":"Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis","volume":"182","author":"Kim","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jctube.2025.100568_b0205","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thoraxjnl-2015-207638","article-title":"Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?","volume":"71","author":"Balabanova","year":"2016","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.jctube.2025.100568_b0210","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.5588\/ijtld.14.0242","article-title":"Longevity loss among cured tuberculosis patients and the potential value of prevention","volume":"18","author":"Hoger","year":"2014","journal-title":"The Int J tuberculosis and lung disease : The official J Inte Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"10.1016\/j.jctube.2025.100568_b0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5588\/ijtld.12.0400","article-title":"Deaths of tuberculosis patients in urban China: a retrospective cohort study","volume":"17","author":"Wang","year":"2013","journal-title":"The Int J tuberculosis and lung disease : The official J Int Union against Tuberculosis Lung Disease"},{"key":"10.1016\/j.jctube.2025.100568_b0220","unstructured":"T. G, A. B, B. W. Survival and predictors of mortality among patients under multi-drug resistant tuberculosis treatment in Ethiopia: St. Peter's specialized tuberculosis hospital, Ethiopia. Ethiopian Health and Nutrition Research Institute (EHNRI), Mekelle University, College of Health Science (MU, CHS), Ethiopia. 2013;Vol.4(No.2):772-783."},{"key":"10.1016\/j.jctube.2025.100568_b0225","unstructured":"Zhou H, Wang WP, FYang. Observation of Clinical Characteristics and Survival Time of Patients with HIV Infection Combined with Pulmonary Tuberculosis and Analysis of Influencing Death Factors. Med & Pharm J Chin PLA. 2018;30(06):38-41. (In Chinese)."},{"key":"10.1016\/j.jctube.2025.100568_b0230","first-page":"611","article-title":"Historical cohort study on the mortality pattern and the related risk factors resulting in pulmonary tuberculosis","volume":"6","author":"Kang","year":"2015","journal-title":"Health Research"},{"key":"10.1016\/j.jctube.2025.100568_b0235","first-page":"6","author":"Wang","year":"2017","journal-title":"Historical cohort study on the mortality pattern and the related risk factors resulting in pulmonary tuberculosis"},{"issue":"05","key":"10.1016\/j.jctube.2025.100568_b0240","first-page":"485","article-title":"Analysis of factors in Guangxi Guigang City of HIV\uff0fTB patient survival time and influence","volume":"33","author":"Zhu","year":"2017","journal-title":"J Med Pest Control"},{"key":"10.1016\/j.jctube.2025.100568_b0245","doi-asserted-by":"crossref","unstructured":"Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, Morvan J. High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet (London, England). Nov 1 1997;350(9087):1298. doi:10.1016\/s0140-6736(05)62475-0.","DOI":"10.1016\/S0140-6736(05)62475-0"},{"key":"10.1016\/j.jctube.2025.100568_b0250","doi-asserted-by":"crossref","unstructured":"Muluneh MA, Zeru AB, Derseh BT, Molla Kebede A. Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter's Specialized Hospital, Addis Ababa, Ethiopia. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale. 2021;2021:6696199. doi:10.1155\/2021\/6696199.","DOI":"10.1155\/2021\/6696199"},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/tmi.12826","article-title":"Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia","volume":"22","author":"Alene","year":"2017","journal-title":"Tropical Med Int health : TM & IH"},{"issue":"11","key":"10.1016\/j.jctube.2025.100568_b0260","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40261-016-0443-6","article-title":"Comparison of effectiveness between delamanid and bedaquiline among patients with multidrug-resistant tuberculosis: a markov model simulation study","volume":"36","author":"Byun","year":"2016","journal-title":"Clin Drug Invest"},{"issue":"10","key":"10.1016\/j.jctube.2025.100568_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002142","article-title":"Tradeoffs in introduction policies for the anti-tuberculosis drug bedaquiline: a model-based analysis","volume":"13","author":"Kunkel","year":"2016","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.jctube.2025.100568_b0270","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1164\/rccm.201908-1576OC","article-title":"Isoniazid preventive therapy in contacts of multidrug-resistant tuberculosis","volume":"202","author":"Huang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jctube.2025.100568_b0275","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/aje\/kwad042","article-title":"Burden of chronic obstructive pulmonary disease attributable to tuberculosis: A microsimulation study","volume":"192","author":"Sy","year":"2023","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.jctube.2025.100568_b0280","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/tmi.13302","article-title":"Adult mortality in sub-Saharan Africa: cross-sectional study of causes of death in Zambia","volume":"24","author":"Chisumpa","year":"2019","journal-title":"Tropical Med Int health : TM & IH"},{"key":"10.1016\/j.jctube.2025.100568_b0285","doi-asserted-by":"crossref","unstructured":"Molie T, Teklemariam Z, Klinkenberg E, et al. Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study. BMC infectious diseases. Sep 18 2019;19(1):818. doi:10.1186\/s12879-019-4411-7.","DOI":"10.1186\/s12879-019-4411-7"},{"issue":"12","key":"10.1016\/j.jctube.2025.100568_b0290","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00002030-199908200-00016","article-title":"Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective","volume":"13","author":"Bell","year":"1999","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0295","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1183\/09031936.05.00047805","article-title":"Cost-effectiveness of isoniazid chemoprevention in close contacts","volume":"26","author":"Diel","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jctube.2025.100568_b0300","doi-asserted-by":"crossref","unstructured":"Jordan TJ, Lewit EM, Reichman LB. Isoniazid preventive therapy for tuberculosis. Decision analysis considering ethnicity and gender. The American review of respiratory disease. Dec 1991;144(6):1357-doi:10.1164\/ajrccm\/144.6.1357.","DOI":"10.1164\/ajrccm\/144.6.1357"},{"issue":"4","key":"10.1016\/j.jctube.2025.100568_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036001","article-title":"The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis","volume":"7","author":"Pho","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jctube.2025.100568_b0310","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-129-10-199811150-00005","article-title":"Short-course prophylaxis against tuberculosis in HIV-infected persons. a decision and cost-effectiveness analysis","volume":"129","author":"Rose","year":"1998","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jctube.2025.100568_b0315","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0962-8479(95)90004-7","article-title":"Isoniazid preventive therapy for pulmonary tuberculosis sequelae: which patients up to which age?","volume":"76","author":"Sarasin","year":"1995","journal-title":"Tubercle and lung disease : The official J Int Union against Tuberculosis and Lung Disease"},{"issue":"12","key":"10.1016\/j.jctube.2025.100568_b0320","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","article-title":"Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis","volume":"127","author":"Salpeter","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0325","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(19)30575-4","article-title":"Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials","volume":"20","author":"Campbell","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jctube.2025.100568_b0330","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/M19-3741","article-title":"Health system costs of treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid in different settings","volume":"173","author":"Bastos","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jctube.2025.100568_b0335","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.12688\/f1000research.74445.1","article-title":"Globalization and life lost due to tuberculosis: evidence from a multi-country study","volume":"10","author":"Sriram","year":"2021","journal-title":"F1000Research"},{"key":"10.1016\/j.jctube.2025.100568_b0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41182-018-0114-9","article-title":"Tuberculosis disease burden and attributable risk factors in Nigeria, 1990-2016","volume":"46","author":"Ogbo","year":"2018","journal-title":"Trop Med Health"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:42:32Z","timestamp":1773297752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579425000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"alternative-id":["S2405579425000592"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100568","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tuberculosis on median survival time and years of potential life lost in patients: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100568"}}